N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia

Journal of Autoimmunity

Volumn 26, Issue 4, 2006, Pages 268-277

  Khan, Naim Akhtar ^a   Yessoufou, Akadiri ^a   Kim, Minji ^a   Hichami, Aziz ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Diabetes; Polyunsaturated fatty acids; Pregnancy; Th1 Th2 dichotomy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY INTAKE; DOWN REGULATION; FEEDING; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MACROSOMIA; MALE; NONHUMAN; PANCREAS; PHENOTYPE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RAT; SPLEEN; STREPTOZOCIN DIABETES; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; CHOLESTEROL; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIET; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; FETAL MACROSOMIA; MALE; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, WISTAR; RNA, MESSENGER; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 33744546831     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.03.003     Document Type: Article

References (66)

1. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?. Diabetes 43 (1994) 613-621
2. Rengarajan J., Szabo S.J., and Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 (2000) 479-483
3. Liblau R.S., Singer S.M., and McDevitt H.O. Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 (1995) 34-38
4. Jaramillo A., Gill B.M., and Delovitch T.L. Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell energy?. Life Sci 55 (1994) 1163-1177
5. Berman M.A., Sandborg C.I., Wang Z., Imfeld K.L., Zaldivar Jr. F., Dadufalza V., et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 157 (1996) 4690-4696
6. Wood S.C., Rao T.D., and Frey A.B. Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4. Cell Immunol 192 (1999) 1-12
7. Muller A., Schott-Ohly P., Dohle C., and Gleichmann H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 205 (2002) 35-50
8. Serreze D.V., Chapman H.D., Post C.M., Johnson E.A., Suarez-Pinzon W.L., and Rabinovitch A. Th1 to Th2 cytokine shifts in non-obese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166 (2001) 1352-1359
9. Merzouk H., and Khan N.A. Implication of lipids in macrosomia of diabetic pregnancy: can n-3 polyunsaturated fatty acids exert beneficial effects?. Clin Sci 105 (2003) 519-529
10. Evers I.M., de Valk H.W., and Visser G.H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Br Med J 328 (2004) 915-920
11. Giordano C. Immunobiology of normal and diabetic pregnancy. Immunol Today 11 (1990) 301-303
12. Roll U., Scheeser J., Standl E., and Ziegler A.G. Alterations of lymphocytes subsets in children of diabetic mothers. Diabetologia 37 (1994) 1132-1141
13. Di Mario U., Dotta F., Garguilo P., Sutherland J., Adreani D., Guy K., et al. Immunology in diabetic pregnancy: activated T-cells in diabetic mothers and neonates. Diabetologia 30 (1987) 66-71
14. Lapolla A, Sanzari MC, Znacanaro F, Masin M, Guerriero A, Piva I, et al. Study on lymphocyte subpopulation in diabetic mothers at delivery and in their newborns. Diabetes Nutr Metab 1999;12:394-399.
15. Giordano C., De Maria R., Mattina A., Stassi G., Todaro M., Pugliese A., et al. Analysis of T-lymphocytte subsets after phyhemagglutinin stimulation in normal and type 1 diabetic mothers and their infants. Am J Reprod Immunol 28 (1982) 65-70
16. El Mohandes A., Touraine J.L., Shurky A.S., and Salle B. Lymphocyte populations and responses to mitogens in infants of diabetic mothers. J Clin Labo Immunol 8 (1982) 25-29
17. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003;38:343-352.
18. James M.J., Proudman S.M., and Cleland L.G. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 68 (2003) 399-405
19. Jolly C.A., Jiang Y.H., Chapkin R.S., and McMurray D.N. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 127 (1997) 37-43
20. Triboulot C, Hichami A, Denys A, Khan NA. Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats. J Nutr 2001;131:2364-2369.
21. Endres S., Meydani S.N., Ghorbani R., Schindler R., and Dinarello C.A. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 54 (1993) 599-603
22. Suresh Y., and Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition 19 (2003) 213-228
23. Maksimovic-Ivanic D., Trajkovic V., Miljkovic D.J., Mostarica Stojkovic M., and Stosic-Grujicic S. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil. Clin Exp Immunol 129 (2002) 214-223
24. Merzouk H., Madani S., Hichami A., Prost J., Belleville J., and Khan N.A. Age related changes in fatty acids in obese offspring of streptozotocin-induced diabetic rats. Obes Res 10 (2002) 703-714
25. Merzouk H., Madani S., Hichami A., Prost J., Moutairou K., Belleville J., et al. Impaired lipoprotein metabolism in obese offspring of streptozotocin-induced diabetic rats. Lipids 8 (2000) 773-781
26. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1995) 911-917
27. Solver H.T., and Lanza E. Quantitative analysis of food fatty acids by capillary gas chromatography. J Am Oil Chem Soc 56 (1979) 933-943
28. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 (2000) 169-193
29. Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30 (2000) 503-512
30. Herold K.C., Vezys V., Sun Q., Viktora D., Seung E., Reiner S., et al. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol 156 (2002) 3521-3527
31. Elder M.E., and Maclaren N.K. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 130 (1983) 1723-1731
32. Serreze D.V., Hamaguchi K., and Leiter E.H. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 2 (1989) 759-776
33. Mordes J.P., and Rossini A.A. Animal models of diabetes. Am J Med 70 (1981) 353-360
34. Rossini A.A., Williams R.M., Appel M.C., and Like A.A. Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature 276 (1978) 182-184
35. Vercheval M., De Hertogh R., Pampfer S., Vanderheyden I., Michiels B., De Bernardi P., et al. Experimental diabetes impairs rat development during the preimplantation period. Diabetologia 33 (1990) 187-191
36. Lopez-Soldado I., and Herrera E. Different diabetogenic response to moderate doses of streptozotocin in pregnant rats, and its long-term consequences in the offspring. Exp Obesity Res 4 (2003) 107-118
37. Aerts L., and Van Assche F.A. Intra-uterine transmission of disease. Placenta 24 (2003) 905-911
38. Oh W., Gelardi N.L., and Cha C.J. The cross-generation effect of neonatal macrosomia in rat pups of streptozotocin-induced diabetes. Pediatr Res 29 (1991) 606-610
39. Buggage R.R., Matteson D.M., Shen de F., Sun B., Tuaillon N., and Chan C.C. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol Invest 32 (2003) 259-273
40. Klein S.L., Bird B.H., and Glass G.E. Sex differences in immune responses and viral shedding following Seoul virus infection in Norway rats. Am J Trop Med Hyg 65 (2001) 57-63
41. Cockfield S.M., Ramassar V., Urmson J., and Halloran P.F. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma. J Immunol 142 (1989) 1120-1128
42. Campbell I.L., Kay T.W., Oxbrow L., and Harrison L.C. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87 (1991) 739-742
43. Serreze D.V., Gaskins H.R., and Leiter E.H. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150 (1993) 2534-2543
44. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 13 (2001) 219-327
45. Makhseed M., Raghupathy R., Azizieh F., Omu A., Al-Shamali E., and Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 16 (2001) 2219-2226
46. Reinhard G., Noll A., Schlebusch H., Mallmann P., and Ruecker A.V. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 245 (1998) 933-938
47. Nishida S., Kanno T., and Nakagawa S. Diabetes-induced and age-related changes in fatty acid proportions of plasma lipids in rats. Lipids 33 (1998) 251-259
48. Singh B., Lauzon J., Venkatraman J., Thomson A.B., Rajotte R.V., and Clandinin M.T. Effect of high/low dietary linoleic acid levels on the function and fatty acid composition of T-lymphocytes of normal and diabetic rats. Diabetes Res 8 (1998) 129-134
49. Wallace A., Miles E.A., Evans C., Stock T.E., Yaqoob P., and Calder P.C. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 69 (2001) 449-457
50. Pennline K.J., Roque-Gaffney E., and Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the non-obese diabetic mouse. Clin Immunol Immunopathol 71 (1994) 169-175
51. Cameron M.J., Arreaza G.A., Zucker P., Chensue S.W., Strieter R.M., Chakrabarti S., et al. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in non-obese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159 (1997) 4686-4692
52. Kleeman R., Scott F.W., Wörz-Pagentert U., Nimal Ratnayake W.M., and Kolb H. Impact of dietary fat on Th1/Th2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats. J Autoimmun 11 (1998) 97-103
53. Khan N.A., Khan A., Savelkoul H.F., and Benner R. Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol 62 (2001) 1315-1323
54. Soulimane-Mokhtari N., Guermouche B., Yessoufou A., Saker M., Moutairou K., Hichami A., et al. Modulation of lipid metabolism by (N-3) PUFA in gestational diabetic rats and their macrosomic offspring. Clin Sci 109 (2005) 287-295
55. Koukkou E., Ghosh P., Lowry C., and Ponston L. Offspring of normal and diabetic rats fed saturated fat in pregnancy demonstrate vascular dysfunction. Circulation 98 (1998) 2899-2904
56. Herrera E. Implications of dietary fatty acids during pregnancy on placental, foetal and postnatal development - a Review. Placenta 23 (2002) S9-S19
57. Ghebremeskel K., Bistanis D., Koukkou E., Lowry C., Poston L., and Crawford M.A. Liver triacylglycerols and free fatty acids in streptozotocin-induced diabetic rats have atypical n-6 and n-3 pattern. Com Biochem Physiol Part C 132 (2002) 349-354
58. Zhang P., Smith R., Chapkin R.S., and McMurray D.N. Dietary (n-3) polyunsaturated fatty acids modulate murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development. J Nutr 135 (2005) 1745-1751
59. Guermouche B., Yessoufou A., Soulimane N., Merzouk H., Moutairou K., Hichami A., et al. (N-3) fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes Res 12 (2004) 1744-1753
60. Bonin A., and Khan N.A. Regulation of calcium signalling by docosahexaenoic acid in human T-cells. Implication of CRAC channels. J Lipid Res 41 (2000) 277-284
61. Aires V., Hichami A., Moutairou K., and Khan N.A. Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br J Pharmacol 140 (2003) 1217-1226
62. Denys A., Hichami A., and Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J Lipid Res 42 (2001) 2015-2020
63. Denys A., Hichami A., and Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol Cell Biochem 232 (2002) 143-148
64. Madani S., Hichami A., Legrand A., Belleville J., and Khan N.A. Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J 15 (2001) 2595-2601
65. Madani S., Hichami A., Charkaoui-Malki M., and Khan N.A. Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. J Biol Chem 279 (2004) 1176-1183
66. Lee M., Ko K.S., Oh S., and Kim S.W. Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. J Control Release 88 (2003) 333-342